Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013;6(1):106-19.
doi: 10.3400/avd.pad.12.01000.

Fourth Asian PAD Workshop

No authors listed

Fourth Asian PAD Workshop

No authors listed. Ann Vasc Dis. 2013.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Event-free survival by PAD status at 5 years1)
Fig. 2
Fig. 2
Event rate of symptomatic or asymptomatic PAD in the elderly (people over 65 years)
Fig. 1
Fig. 1
Global projections for diabetes epidemic from 2003 to 20251)
Fig. 1
Fig. 1
Clinical work of Dr Roman Oabel, who has used beraprost
Fig. 1
Fig. 1
Severe ulceration of the patient’s left foot
Fig. 2
Fig. 2
PVR (a) and CT lower extremities angiography (b) results for the 51 year old male patient
Fig. 3
Fig. 3
Successful healing following peripheral angioplasty
Fig. 1
Fig. 1
Frequency distribution of lower ABI in all diabetic subjects
Fig. 2
Fig. 2
Frequency distribution of lower ABI in elderly diabetic subjects
Fig. 3
Fig. 3
Rate of previous diagnosis and treatment of PAD patients
Fig. 4
Fig. 4
Outcomes of PAD patients with diabetes from KPSA
Fig. 5
Fig. 5
Effects of beraprost on coldness of limbs and numbness
Fig. 6
Fig. 6
Effect of beraprost on the incidence of systemic vascular events (meta-analysis)
Fig. 7
Fig. 7
Beraprost improves insulin transfer into skeletal muscles and reduce insulin resistance
Fig. 1
Fig. 1
Risk factors for PAD–10)
Fig. 2
Fig. 2
Change in peak walking time in PAD patients
Fig. 3
Fig. 3
Results of the meta analysis of cilostazol studies11)
See this image and copyright information in PMC

References

    1. Diehm C, Allenberg JR, Pittrow D, et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009; 120: 2053–61 - PubMed
    1. Rooke TW, Hirsch AT, Misra S, et al. 2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline). J Am Coll Cardiol 2011; 58:2020–45 - PMC - PubMed
    1. Saeki N, et al. J Jpn Coll Angiol 2012; 52: 303–8
    1. Zimmet P, Shaw J, Alberti KG. Preventing Type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view. Diabet Med 2003; 20: 693–702 - PubMed
    1. Aekplakorn W, Abbott-Klafter J, Premgamone A, et al. Prevalence and management of diabetes and associated risk factors by regions of Thailand: Third National Health Examination Survey 2004. Diabetes Care 2007; 30: 2007–12 - PubMed

LinkOut - more resources